Dan Riskin | Source | CEO, founder, and global healthcare RWE & AI expert at Verantos

Dan Riskin, MD, MBA, is the founder and CEO of Verantos, a company dedicated to using high-validity, real-world evidence to drive change and equality in healthcare. Dan is widely regarded as a global expert on healthcare artificial intelligence and real-world evidence and how they can help address diversity and equity in clinical trials.

Dan promoted healthcare quality improvement and shaped policy when he provided Congressional testimony that eventually led to the passing of the 21st Century Cures Act, a law designed to incorporate real-world evidence into regulatory decision-making. He also served on the Obama Healthcare Policy Committee for the 2008 Presidential Campaign and works with the Biden administration on efforts including the HHS Quality Measurement Task Force. He continues to practice, teach, and perform research as Adjunct Professor of Surgery and Adjunct Professor of Biomedical Informatics Research at Stanford University.